Overview

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors

Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is a phase 1b study of Indibulin in combination with Capecitabine in advanced solid tumors.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ziopharm
Treatments:
Capecitabine